ClinicalTrials.Veeva

Menu

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

M

Medical University of Graz

Status and phase

Completed
Phase 4

Conditions

Type 1 Diabetes

Treatments

Drug: Cholecalciferol

Study type

Interventional

Funder types

Other

Identifiers

NCT01390480
ENM-DA-017

Details and patient eligibility

About

In this placebo controlled study the investigators aim to investigate the effects of vitamin D supplementation in subjects with new onset of type 1 diabetes on immunological, endocrine and metabolic parameters.

Full description

This is a bicentric, randomized placebo controlled, double blind study, with the aim to evaluate the effect of vitamin D supplementation in subjects with new onset of type 1 diabetes on immunological, endocrine and metabolic parameters.

The primary study goal is to evaluate the influence of vitamin D supplementation on the number and function of the master regulatory T-cells under controlled conditions within 13 months. The secondary study goals are a comprehensive immune phenotyping to determine whether Vit D produces changes consistent with a general improvement in immune homeostasis that supports ß-cell tolerating interventions, the assessment of ß-cell function in all subjects to obtain preliminary data on the effects of Vit D on ß-cell survival.

Enrollment

31 patients

Sex

All

Ages

6 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • males or females > 6 years
  • new onset of type 1 diabetes (3 months)

Exclusion criteria

  • pregnancy
  • hypercalcemia (>2,65 mmol/L)
  • chronic disease including a long-term medication over 4 weeks per year (except type 1 diabetes)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

31 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
peanut oil
Treatment:
Drug: Cholecalciferol
Vitamin D (Oleovit®)
Active Comparator group
Description:
cholecalciferol
Treatment:
Drug: Cholecalciferol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems